Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Ades Alan A., Director. Director active across 1 company, notably Organogenesis Holdings Inc.. In total, 6 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €52.3m. Activity tracked since 6 May 2021. The latest transaction was disclosed on 9 January 2025 (Don). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Alan A. Ades is a Director at Organogenesis Holdings Inc. As a board member, he contributes to the governance and strategic direction of the company. Alan brings his expertise to help guide decisions that support the mission and objectives of Organogenesis.